Institut Curie

OrganisationROR

Trials

  • NCT06195709

    Phase 3, Recruiting, 300 people, 8 Jan 2024

  • NCT05439005

    Phase 3, Recruiting, 158 people, 30 Jun 2022

  • NCT04681417

    Phase 2/3, Recruiting, 225 people, 23 Dec 2020

  • NCT04446962

    Phase 1/2, Active, not recruiting, 118 people, 25 Jun 2020

  • NCT03298893

    Phase 1/2, Completed, 21 people, 2 Oct 2017

  • NCT02870907

    Phase 2, Active, not recruiting, 195 people, 17 Aug 2016

  • NCT02866136

    Phase 2, Active, not recruiting, 133 people, 15 Aug 2016

  • NCT02028923

    Phase 3, Terminated, 126 people, 7 Jan 2014

  • NCT01868269

    Phase 3, Completed, 102 people, 4 Jun 2013

  • NCT01180335

    Collaborator, Phase 3, Completed, 303 people, 12 Aug 2010

Grants and prizes

  • European Commission

    HORIZON-TMA-MSCA-PF-EF, How 3D genome organization allows cells to learn and remember their identity, 101277985, €242.3k, 2026–2028, 8 Apr 2026

  • European Commission

    HORIZON-IA, Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome, 101213916, €196.1k, 2025–2031, 14 May 2025

Sources: cordis.europa.eu